How Ozempic helps manage fatty liver disease Ozempic's active ingredient is semaglutide, a GLP-1 receptor agonist that manages blood sugar by increasing insulin levels, slowing gastric emptying ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol.

which involved around 800 patients treated with semaglutide or placebo on top of standard care and followed for 72 weeks. MASH is a form of non-alcoholic fatty liver disease (NAFLD) that affects ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for ...

"Adherence improves when treatment integrates easily into patients’ lives," explains Adam McBride, Eden’s CEO. Eden’s digital ...

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...